Study Complete
Sponsor ID
20060364
Ancillary study to protocol 20060104
Study Details
Ancillary study to the Etanercept protocol 20060104. Subjects have been asked to provide additional blood samples for further assessment.
Protocol Summary
Primary Outcome Measures
To explore the correlation between pheripheral blood cell protein phosphorylation assessemnts and rheumatoid arthritis disease activity.
Timeframe: week 24
Secondary Outcome Measures
Explore the correlations to etanercept clinical response (ACR and DAS scores) may also be explored.
Timeframe: week 24
Locations
No locations found.